Lenalidomide and Prednisone in Treating Patients With Myelofibrosis

Clinical trial NCT00227591 · COMPLETED

Trial details

NCT number: NCT00227591
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Essential Thrombocythemia Polycythemia Vera Primary Myelofibrosis

Start date: 2005-12-01
Primary completion: 2010-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.